Gene therapy for cystic fibrosis is advancing rapidly but drug therapy is quickly catching up (pages 467–469).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Crystal, R.G. Transfer of genes to humans: Early lessons and obstacles to success. Science 270, 404–410 (1995).
Welsh, M.J. & Smith, A.E. Cystic fibrosis. Sci. Am. 273 (Dec.), 52–59 (1995).
Howard, M. et al. Aminoglycoside antibiotics restore CFTR function by suppressing premature stop mutations. Nature Med. 2, 467–469 (1996).
Welsh, M.J. & Smith, A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73, 1251–1254 (1993).
Sheppard, D.N. et al. The amino-terminal portion of CFTR forms a regulated Cl− channel. Cell 76, 1091–1098 (1994).
Sato, S. et al. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J. Biol. Chem. 271, 635–638 (1996).
Becq, F. et al. Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc. Natl. Acad. Sci. USA 91, 9160–9164 (1994).
Stutts, M.J. et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 269, 847–850 (1995).
Schwiebert, E.M. et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81, 1063–1073 (1995).
Knowles, M.R. et al. A pilot study of aerosolized amiloride fro the treatment of lung disease in cystic fibrosis. N. Engl. J. Med. 322, 1189–1194 (1990).
Noone, P.G. et al. Modulation of the ionic milieu of the airway in health and disease. Annu. Rev. Med. 45, 421–434 (1994).
Colledge, W.H. et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nature Genet. 10, 445–452 (1995).
Zeiher, B.G. et al. A mouse model for the ΔF508 allele of cystic fibrosis. J. Clin. Invest. 96, 2051–2064 (1995).
Delaney, S.J. et al. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO J. 15, 955–963 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Delaney, S., Wainwright, B. New pharmaceutical approaches to the treatment of cystic fibrosis. Nat Med 2, 392–393 (1996). https://doi.org/10.1038/nm0496-392
Issue Date:
DOI: https://doi.org/10.1038/nm0496-392